BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16894287)

  • 1. The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications.
    Fisher SG; Fisher RI
    Curr Opin Oncol; 2006 Sep; 18(5):417-24. PubMed ID: 16894287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of non-Hodgkin's lymphoma.
    Fisher SG; Fisher RI
    Oncogene; 2004 Aug; 23(38):6524-34. PubMed ID: 15322522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
    Smedby KE; Baecklund E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.
    Smedby KE; Askling J; Mariette X; Baecklund E
    J Intern Med; 2008 Dec; 264(6):514-27. PubMed ID: 19017176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host immune response in B-cell lymphomas: friend or foe?
    Juszczyński P; Nowak J; Warzocha K
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):245-55. PubMed ID: 18726146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and etiology of non-Hodgkin lymphoma--a review.
    Ekström-Smedby K
    Acta Oncol; 2006; 45(3):258-71. PubMed ID: 16644568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics.
    Chua I; Quinti I; Grimbacher B
    Curr Opin Hematol; 2008 Jul; 15(4):368-74. PubMed ID: 18536576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph.
    Becker N; de Sanjose S; Nieters A; Maynadié M; Foretova L; Cocco PL; Staines A; Alvaro T; Vornanen M; Brennan P; Boffetta P
    Leuk Res; 2007 Oct; 31(10):1365-72. PubMed ID: 17481729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis: immunopathogenesis and controversies in defining the cause.
    Holmøy T; Hestvik AL
    Curr Opin Infect Dis; 2008 Jun; 21(3):271-8. PubMed ID: 18448972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
    Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoproliferative disease of the orbit.
    Bernardini FP; Bazzan M
    Curr Opin Ophthalmol; 2007 Sep; 18(5):398-401. PubMed ID: 17700233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
    Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
    J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk.
    Nieters A; Beckmann L; Deeg E; Becker N
    Genes Immun; 2006 Dec; 7(8):615-24. PubMed ID: 16971956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
    Tzioufas AG; Voulgarelis M
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic lymphoma: epidemiology and pathogenesis.
    Sjö LD
    Acta Ophthalmol; 2009 Feb; 87 Thesis 1():1-20. PubMed ID: 19178392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of peripheral T-cell lymphomas.
    O'leary H; Savage KJ
    Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation against leukemias and lymphomas: a realistic future treatment?
    Mittal S; Marshall NA; Barker RN; Vickers MA
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):101-8. PubMed ID: 17719232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viruses and lymphoma.
    Gandhi MK; Khanna R
    Pathology; 2005 Dec; 37(6):420-33. PubMed ID: 16373225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.